Dr. Augustine is the Robert J. Joynt Associate Professor of Neurology, Pediatrics, and the Center for Health + Technology (CHeT) at the University of Rochester. Following residency training in Pediatrics and Pediatric Neurology at Harvard University/Boston Children’s Hospital, Dr. Augustine completed dual fellowships in Pediatric Movement Disorders and Experimental Therapeutics, with a focus on clinical trial design.

Dr. Augustine specializes in the care of children with movement disorders. Her clinical research program focuses on advancing therapeutic development for rare pediatric neurological disorders, with emphasis on comprehensive clinical phenotyping and trial design. Dr. Augustine leads clinical programs developing novel therapeutics for the neuronal ceroid lipofuscinoses (Batten diseases), a group of rare pediatric neurodegenerative disorders.

Scott Steele, PhD is the Director of Regulatory Science Programs in the Clinical and Translational Science Institute at the University of Rochester and associate professor in the Department of Public Health Sciences. Prior to joining the University of Rochester, he served in the White House Office of Science and Technology Policy. He completed his MA and PhD in Molecular Biology at Princeton University. Dr. Steele develops and leads regulatory science and translational science programs, including as Director of the Regulatory Science to Advance Precision Medicine Initiative that evaluates emerging science and regulatory considerations for areas such as digital health, biomanufacturing, regenerative medicine and genomics. He currently serves on the FDA Science Board.